argenx SE - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ARGX Nasdaq 2830 www.argenx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for argenx SE

Earnings Estimates Rising for Argenx (ARGX): Will It Gain? - Jan 17th, 2025 5:20 pm
argenx Highlights 2025 Strategic Priorities - Jan 13th, 2025 6:00 am
argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference - Jan 6th, 2025 6:00 am
Exploring High Growth Tech Stocks for January 2025 - Jan 1st, 2025 4:08 pm
Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment - Dec 28th, 2024 11:28 am
argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy - Dec 27th, 2024 6:00 am
Is Argenx SE (ARGX) the Best Performing Biotech Stock in 2024? - Dec 23rd, 2024 3:28 pm
Here’s Why argenx SE (ARGX) Surged in Q3 - Dec 12th, 2024 2:30 pm
Should You Increase Your Holdings in argenx SE (ARGX)? - Dec 9th, 2024 2:10 pm
Three Stocks Estimated To Be Undervalued In December 2024 - Dec 3rd, 2024 4:06 am
Spotlight On High Growth Tech Stocks This December 2024 - Dec 3rd, 2024 1:07 am
Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now? - Dec 2nd, 2024 7:55 pm
argenx to Present at Upcoming Investor Conferences - Nov 26th, 2024 6:00 am
Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial - Nov 22nd, 2024 10:30 am
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies - Nov 20th, 2024 6:00 am
Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now? - Nov 18th, 2024 2:10 pm
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China - Nov 11th, 2024 12:30 pm
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China - Nov 11th, 2024 12:30 pm
Why Argenx (ARGX) Might be Well Poised for a Surge - Nov 5th, 2024 5:20 pm
argenx to Participate at Upcoming Investor Conferences - Nov 5th, 2024 6:00 am